Halozyme Therapeutics (HALO)
NASDAQ:HALO
Holding HALO?
Track your performance easily

Halozyme (HALO) Financial Statements

910 Followers

Halozyme Financial Overview

Halozyme's market cap is currently ―. The company's EPS TTM is $3.022; its P/E ratio is 20.21; Halozyme is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $1.17. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 290.08M$ 231.35M$ 195.88M$ 230.04M$ 216.03M
Gross Profit$ 240.66M$ 191.75M$ 167.55M$ 177.74M$ 161.21M
EBIT$ 165.15M$ 117.74M$ 100.53M$ 106.39M$ 101.76M
EBITDA$ 187.35M$ 142.31M$ 120.16M$ 127.09M$ 126.72M
Net Income Common Stockholders$ 137.01M$ 97.77M$ 76.82M$ 85.39M$ 81.84M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 666.31M$ 529.03M$ 463.45M$ 336.00M$ 483.28M
Total Assets$ 2.12B$ 1.97B$ 1.84B$ 1.73B$ 1.89B
Total Debt$ 1.50B$ 1.50B$ 1.50B$ 1.50B$ 1.50B
Net Debt$ 837.85M$ 973.49M$ 1.04B$ 1.16B$ 1.01B
Total Liabilities$ 1.67B$ 1.68B$ 1.66B$ 1.65B$ 1.64B
Stockholders Equity$ 452.70M$ 289.42M$ 177.81M$ 83.81M$ 249.18M
Cash Flow-
Free Cash Flow$ 113.86M$ 53.21M$ 125.88M$ 99.76M$ 129.47M
Operating Cash Flow$ 115.38M$ 55.79M$ 129.43M$ 102.35M$ 132.41M
Investing Cash Flow$ -167.48M$ -42.04M$ -82.68M$ -8.29M$ -83.45M
Financing Cash Flow$ 18.56M$ 9.48M$ -489.00K$ -249.92M$ 4.10M
Currency in USD

Halozyme Earnings and Revenue History

Halozyme Debt to Assets

Halozyme Cash Flow

Halozyme Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis